GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

As the U.S.–Iran ceasefire takes shape, cyber warfare continues unchecked. Why ignoring cyber risks leaves critical ...

Deloitte will reduce parental leave, paid time off, and other benefits for a segment of its US workforce under a new talent ...

The Bihar Cabinet has greenlit plans for a luxurious five-star heritage hotel at the Sultan Palace, a remarkable edifice ...